Abstract:Exosomes or small extracellular vesicles are considered a new generation of bioinspired-nanoscale drug delivery system (DDS). Endogenous exosomes function as signalosomes since they convey signals via ligands or adhesion molecules located on the exosomal membrane, or packaged inside the exosome. Recently, exosome membrane modification, therapeutic payloads encapsulation, and modulation of in vivo disposition of exosomes have been extensively investigated, among which significant advances have been made to optimize exosome-mediated delivery to solid tumors. Exosomes, specifically tumor cell-derived exosomes, are presumed to have tumor-preferential delivery due to the homotypic features. However, quality attributes that dictate the tissue distribution, cell type-selective uptake, and intracellular payload release of the administered exosomes, as well as the spatiotemporal information regarding exosome fate in vivo, remain to be further investigated. This review summarizes recent advances in developing exosomes as drug delivery platforms with a focus on tumor targeting. The pharmacokinetic features of naive exosomes and factors influencing their intracellular fate are summarized. Recent strategies to improve tumor targeting of exosomes are also reviewed in the context of the biological features of tumor and tumor microenvironment (TME). Selected approaches to augment tumor tissue deposition of exosomes, as well as methods to enhance intracellular payload delivery, are summarized with emphasis on the underlying mechanisms (eg, passive or active targeting, endosomal escape, etc.). In conclusion, this review highlights recently reported tumor-targeting strategies of exosome-based drug delivery, and it's in the hope that multiple approaches might be employed in a synergistic combination in the development of exosome-based cancer therapy.

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape

Transporting Carriers for Intracellular Targeting Delivery Via Non-Endocytic Uptake Pathways

Cell-Penetrating Peptides as Keys to Endosomal Escape and Intracellular Trafficking in Nanomedicine Delivery

Advanced strategies for overcoming endosomal/lysosomal barrier in nanodrug delivery

The role of endosome evasion bypass in the reversal of multidrug resistance by lipid/nanoparticle assemblies

Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery

Endolysosomal trapping of therapeutics and endosomal escape strategies

Coating nanoparticles with cell membranes for targeted drug delivery

Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery

Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release

An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids

Charge-guided Masking of a Membrane-Destabilizing Peptide Enables Efficient Endosomal Escape for Targeted Intracellular Delivery of Proteins

Overcoming Endosomal Escape Barriers in Gene Drug Delivery Using De Novo Designed Ph-Responsive Peptides

The Cell-Type Specificity And Endosomal Escape Of Cell-Penetrating Peptides

Subcellular targeting strategies for protein and peptide delivery

Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals

Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate

Intracellular delivery strategies using membrane-interacting peptides and proteins

Micro- and nanotechnologies for intracellular delivery.

Earlier endosomal escape improves the catalytic activity of delivered enzyme cargo